News Center

• 25October

  Ever Supreme is registered for pre-OTC, ...

  Ever Supreme (6712)  is registered for pre-OTC, recommend price is NT$50 per share.  Benef...

• 09March

  Participation in the Cell Therapy Manufa...

  Dr. Hsiu-Ling Hsiao(CSO) had be invited to participate as a speaker and lead discussion at...

• 08February

  FDA APPROVAL FOR A CLINICAL PHASE I TRIA...

  FDA APPROVAL FOR A CLINICAL PHASE I TRIAL WITH ITS NEW MYOCARDIAL INFARCTION DRUG